Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Early Breast Cancer | Phase3 | Australia Canada China Germany Hong Kong India Israel Mexico Portugal South Korea Taiwan Turkey (Türkiye) United States View all |
NCT05827081 |
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
Metastatic Hormone-sensitive Prostate Cancer | Phase2 | Australia Czechia France Germany Italy Netherlands Poland Singapore South Korea Spain Taiwan United States View all |
NCT06991556 |
Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies |
Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma | Brazil | NCT05541341 | |
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | NCT05809986 | |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
Prostate Cancer | Phase4 | Austria Belgium Canada Czechia France Germany Netherlands Spain Sweden United Kingdom United States View all |
NCT05803941 |
RWE Non-Interventional Prospective Study of Ribociclib Effectiveness and Safety in Patients With HR+/HER2- Early Breast Cancer in Saudi Arabia |
HR+/HER2- Early Breast Cancer | Saudi Arabia | NCT06797531 | |
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study |
Atherosclerotic Vascular Disease, Heterozygous Familial Hypercholesterolemia | Spain | NCT06958315 | |
Iptacopan in Patients With ANCA Associated Vasculitis |
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis | Phase2 | Argentina Australia Austria Belgium Canada China Czechia Denmark France Germany Hungary Netherlands Spain Turkey (Türkiye) United Kingdom United States View all |
NCT06388941 |
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease |
Sickle Cell Disease | Phase1, Phase2 | United States | NCT06546670 |
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® |
Asthma | South Korea | NCT05217810 |